| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/06/2005 | EP1519752A1 Use of cetp inhibitors and antihypertensive agents as well as optionally hmg coa reductase inhibitors |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519735A2 Assays and implements for determining and modulating hsp90 binding activity |
| 04/06/2005 | EP1519732A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1480627A4 Methods of reducing angiogenesis |
| 04/06/2005 | EP1414817B1 substituted isoindoles and the use thereof |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP1334086B1 Phenoxyphenyl alkane sulfonates |
| 04/06/2005 | EP1311258B1 Compositions containing hypotriglyceridemically active stilbenoids |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1214084B1 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 04/06/2005 | EP1113809B1 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 04/06/2005 | EP1090012A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP1090011A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1604893A Cyclic amine compounds |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1604774A 血管生成抑制剂 An angiogenesis inhibitor |
| 04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1602960A Mixture for preventing and treating metabolic syndrome like cerebrovascular and cardiovascular disease |
| 04/06/2005 | CN1602948A Gingko leaf dispersible tablet and its preparing process |
| 04/06/2005 | CN1602940A Orally quick releasing tablet of compound red sage root, its medical uses and preparation process |
| 04/06/2005 | CN1602939A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 04/06/2005 | CN1602926A Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases |
| 04/06/2005 | CN1602920A Gingko leaf extracts with superior quality and its manufacturing technique |
| 04/06/2005 | CN1602919A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 04/06/2005 | CN1602918A Astragalus root and Breviscapine containing Chinese medicinal formulation and its preparation and application |
| 04/06/2005 | CN1602917A 'Shengmai' formulation and its preparation process |
| 04/06/2005 | CN1602916A Medicine for treating piles and its preparing process |
| 04/06/2005 | CN1602902A Medicine for treating angina and preparation technology thereof |
| 04/06/2005 | CN1602893A Pharmaceutical composition for treating cerebral apoplexy and its preparation method |
| 04/06/2005 | CN1602884A Blood vessel dredging capsule containing panax pseudo-ginseng tri-alclhol saponin and its preparation process |
| 04/06/2005 | CN1602883A Pharmaceutical compositions containing ginsenoside, safflor yellow and its preparation and application |
| 04/06/2005 | CN1602875A MolsidominE dripping pills and its preparation process |
| 04/06/2005 | CN1602863A Dripping pills of furazabol and its preparation method |
| 04/06/2005 | CN1602857A Orally disintegrating tablet of safflor yellow and its preparation process |
| 04/06/2005 | CN1602849A Propranolol hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602847A Bupicomide hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602846A Oxyfenamate hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602845A Fenfluramine hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1195858C OB fusion protein compositions and methods |
| 04/06/2005 | CN1195773C Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2005 | CN1195772C Nb heterocyclic 8-modified adenosine derivs. |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195537C External-applied Chinese medicine for treating hypertension and its preparing process |
| 04/06/2005 | CN1195524C Use of benzenesulfonyl (thio) ureas in combination with beta-receptor retarder for treatment and prophylaxis of dysfunctions of autonomous nervous system |
| 04/06/2005 | CN1195523C Topical compositions for prostaglandin E1 delivery |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/06/2005 | CN1195508C Use of inhibitors of sodium-hydrogen pump for production of medicament for decreaing undesired effects of substances on heart |
| 04/06/2005 | CN1195502C Periadventitial delivery device |
| 04/06/2005 | CN1195497C Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 04/06/2005 | CN1195494C Oral liquid mucoadhesive compositions |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875791 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | US6875788 Non-insulin dependent diabetes, antidiabetic agents, dietetics, antilipemic agents, anticholesterol agents, cardiovascular disorders |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875777 Compounds |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | CA2371012C 4-(1h-pyrrol-1-yl) imidazoles |
| 04/05/2005 | CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 04/05/2005 | CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 04/05/2005 | CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028476A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 03/31/2005 | WO2005028463A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028455A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 03/31/2005 | WO2005028453A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | WO2005028451A1 Tetrahydroquinoxalines and their use as m2 acetylcholine receptor agonists |
| 03/31/2005 | WO2005028441A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | WO2005028439A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028438A1 Novel piperidine derivative |
| 03/31/2005 | WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives |